(n=5 per group). ap<0.0001, bp<0.05 significantly different from the diabetic group . D: Diabetic group LevD: Potassium channel activated diabetic group LevDG: Potassium channel activated diabetic group treated with glibenclamide LevDM: Potassium channel activated diabetic group treated with metformin LevDI20: Potassium channel activated diabetic group treated with 20 i.u/kg insulin LevDI40 : Potassium channel activated diabetic group treated with 40 i.u/kg insulin |
||||||||||||||||||||||||||||||||||||||||
Table 2: The effects of levcromakalim on the creatinine and urea of streptozotocin-induced diabetic rats treated with glibenclamide (5 mg/kg), metformin (350 mg/kg) and insulin (5 & 10 i.u/kg). |